Objective:Discusses the effectiveness and safety on Adalinumab for Juvenile idiopathic arthritis.Method:20 JIA cases from August 2011 to December 2011 in ou
Stevens-Johnson syndrome (SJS) is a complex immunological syndrome with high morbidityand mortality and characterized by acute blistering affecting the skin